Skip to main content
. 2019 Apr 29;8(6):2877–2885. doi: 10.1002/cam4.2204

Figure 2.

Figure 2

Prognostic score for (DFS) of (GC) patients with peritoneal metastases who underwent combined therapy with (HIPEC). DFS, disease‐free survival; overall survival; GC, gastric cancer; HIPEC, hyperthermic intraperitoneal chemotherapy